{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:45:02Z","timestamp":1778949902945,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,6]]},"DOI":"10.7759\/cureus.80177","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:01:09Z","timestamp":1741320069000},"source":"Crossref","is-referenced-by-count":1,"title":["Hypercalcemia Complicated by Rhabdomyolysis and Acute Kidney Injury"],"prefix":"10.7759","author":[{"given":"Kyosuke","family":"Omata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch X","year":"2009","unstructured":"Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009, 361:62-72. 10.1056\/NEJMra0801327","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Rhabdomyolysis: Pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres PA","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: Pathogenesis, diagnosis, and treatment. Ochsner J. 2015, 15:58-69.","journal-title":"Ochsner J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0606-8","article-title":"Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients","volume":"9","author":"Mousseaux C","year":"2019","unstructured":"Mousseaux C, Dupont A, Rafat C, et al.. Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients. Ann Intensive Care. 2019, 9:133. 10.1186\/s13613-019-0606-8","journal-title":"Ann Intensive Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: A review","volume":"328","author":"Walker MD","year":"2022","unstructured":"Walker MD, Shane E. Hypercalcemia: A review. JAMA. 2022, 328:1624-36. 10.1001\/jama.2022.18331","journal-title":"JAMA"},{"key":"ref5","article-title":"Calcium metabolism in acute renal failure due to rhabdomyolysis","volume":"39","author":"Hadjis T","year":"1993","unstructured":"Hadjis T, Grieff M, Lockhat D, Kaye M. Calcium metabolism in acute renal failure due to rhabdomyolysis. Clin Nephrol. 1993, 39:22-7.","journal-title":"Clin Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.10.045","article-title":"Biphasic hypercalcemia in severe rhabdomyolysis: Serial analysis of PTH and vitamin D metabolites. A case report and literature review","volume":"43","author":"Shrestha SM","year":"2004","unstructured":"Shrestha SM, Berry JL, Davies M, Ballardie FW. Biphasic hypercalcemia in severe rhabdomyolysis: Serial analysis of PTH and vitamin D metabolites. A case report and literature review. Am J Kidney Dis. 2004, 43:e31-5. 10.1053\/j.ajkd.2003.10.045","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne RB","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973, 4:643-6. 10.1136\/bmj.4.5893.643","journal-title":"Br Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.891046","article-title":"Severe hypercalcemia complicating recovery of acute kidney injury due to rhabdomyolysis","volume":"15","author":"Hechanova LA","year":"2014","unstructured":"Hechanova LA, Sadjadi SA. Severe hypercalcemia complicating recovery of acute kidney injury due to rhabdomyolysis. Am J Case Rep. 2014, 15:393-6. 10.12659\/AJCR.891046","journal-title":"Am J Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3918\/jsicm.29_141","article-title":"A case of delayed hypercalcemia during diuretic phase of acute kidney injury due to rhabdomyolysis: Evaluation of heterotopic calcification by serial CT","volume":"29","author":"Ikechi D","year":"2022","unstructured":"Ikechi D, Koga Y, Harada K, Yagi T, Todani M, Fujita M, Tsuruta R. A case of delayed hypercalcemia during diuretic phase of acute kidney injury due to rhabdomyolysis: Evaluation of heterotopic calcification by serial CT. J Jpn Soc Intensive Care Med. 2022, 29:141-5. 10.3918\/jsicm.29_141","journal-title":"J Jpn Soc Intensive Care Med"},{"key":"ref10","article-title":"Hypercalcemia in association with acute renal failure and rhabdomyolysis. Case report and literature review","volume":"19","author":"Meneghini LF","year":"1993","unstructured":"Meneghini LF, Oster JR, Camacho JR, Gkonos PJ, Roos BA. Hypercalcemia in association with acute renal failure and rhabdomyolysis. Case report and literature review. Miner Electrolyte Metab. 1993, 19:1-16.","journal-title":"Miner Electrolyte Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198107163050301","article-title":"The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol","volume":"305","author":"Llach F","year":"1981","unstructured":"Llach F, Felsenfeld AJ, Haussler MR. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. N Engl J Med. 1981, 305:117-23. 10.1056\/NEJM198107163050301","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-1-137","article-title":"Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure","volume":"63","author":"Akmal M","year":"1986","unstructured":"Akmal M, Bishop JE, Telfer N, Norman AW, Massry SG. Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. J Clin Endocrinol Metab. 1986, 63:137-42. 10.1210\/jcem-63-1-137","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","article-title":"Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption","volume":"52","author":"Halleen JM","year":"2006","unstructured":"Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, V\u00e4\u00e4n\u00e4nen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab. 2006, 52:499-509.","journal-title":"Clin Lab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0826-4","article-title":"Is calcium replacement therapy unnecessary for severe hypocalcemia associated with rhabdomyolysis?","volume":"18","author":"Imai R","year":"2014","unstructured":"Imai R, Akimoto T, Takeda S, Muto S, Kusano E. Is calcium replacement therapy unnecessary for severe hypocalcemia associated with rhabdomyolysis?. Clin Exp Nephrol. 2014, 18:172-3. 10.1007\/s10157-013-0826-4","journal-title":"Clin Exp Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i19.3111","article-title":"Primary hypoparathyroidism accompanied by rhabdomyolysis induced by infection: A case report","volume":"7","author":"Ding LN","year":"2019","unstructured":"Ding LN, Wang Y, Tian J, Ye LF, Chen S, Wu SM, Shang WB. Primary hypoparathyroidism accompanied by rhabdomyolysis induced by infection: A case report. World J Clin Cases. 2019, 7:3111-9. 10.12998\/wjcc.v7.i19.3111","journal-title":"World J Clin Cases"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000188386","article-title":"Hypertensive emergency due to hypercalcemia after acute renal failure secondary to rhabdomyolysis","volume":"69","author":"Bedani PL","year":"1995","unstructured":"Bedani PL, Gilli P. Hypertensive emergency due to hypercalcemia after acute renal failure secondary to rhabdomyolysis. Nephron. 1995, 69:120-1. 10.1159\/000188386","journal-title":"Nephron"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4021\/jmc943w","article-title":"Reversible myocardial calcification following severe leptospirosis complicated with rhabdomyolysis-induced acute kidney injury and magnesium-wasting nephropathy","volume":"4","author":"Zakout R","year":"2013","unstructured":"Zakout R, do Carmo M, Freitas P. Reversible myocardial calcification following severe leptospirosis complicated with rhabdomyolysis-induced acute kidney injury and magnesium-wasting nephropathy. J Med Cases. 2013, 4:92-8. 10.4021\/jmc943w","journal-title":"J Med Cases"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21671","article-title":"Hypercalcemia in a 67-year-old female following the use of calcium sulfate beads: A case report and review of literature","volume":"14","author":"Alkaissi HR","year":"2022","unstructured":"Alkaissi HR, McFarlane SI. Hypercalcemia in a 67-year-old female following the use of calcium sulfate beads: A case report and review of literature. Cureus. 2022, 14:e21671. 10.7759\/cureus.21671","journal-title":"Cureus"},{"key":"ref19","article-title":"Hyperphosphatemic familial tumoral calcinosis","author":"Ramnitz MS","year":"2018","unstructured":"Ramnitz MS, Gafni RI, Collins MT. Hyperphosphatemic familial tumoral calcinosis. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (ed): University of Washington, Seattle, Seattle, WA; 2018."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4574-x","article-title":"Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: A report of two affected families and review of the literature","volume":"29","author":"Chakhtoura M","year":"2018","unstructured":"Chakhtoura M, Ramnitz MS, Khoury N, et al.. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: A report of two affected families and review of the literature. Osteoporos Int. 2018, 29:1987-2009. 10.1007\/s00198-018-4574-x","journal-title":"Osteoporos Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10185","article-title":"Hyperphosphatemic familial tumoral calcinosis with Galnt3 mutation: Transient response to anti-interleukin-1 treatments","volume":"3","author":"Dauchez A","year":"2019","unstructured":"Dauchez A, Souffir C, Quartier P, Baujat G, Briot K, Roux C. Hyperphosphatemic familial tumoral calcinosis with Galnt3 mutation: Transient response to anti-interleukin-1 treatments. JBMR Plus. 2019, 3:e10185. 10.1002\/jbm4.10185","journal-title":"JBMR Plus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338201-hypercalcemia-complicated-by-rhabdomyolysis-and-acute-kidney-injury","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:02:32Z","timestamp":1741320152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338201-hypercalcemia-complicated-by-rhabdomyolysis-and-acute-kidney-injury"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.80177","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}